Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Integra Biosciences AG has 3 pending office actions within the Chemistry & Materials technology area. All of these actions are concentrated within 1 distinct art unit, suggesting a specific technical focus for the current portfolio. Despite this concentration, the prosecution involves 3 distinct examiners, meaning different individuals are reviewing the applications within that single art unit. This provides the company with multiple perspectives on how its chemistry-related claims are interpreted within a single specialized group.
NOGUEROLA, ALEXANDER STEPHAN is the busiest examiner with 1 pending office action. Since each of the 3 distinct examiners handles 1 of the 3 pending office actions, the company must manage these separate examiner relationships within its 1 distinct art unit. This structure allows for a comparison of examiner behavior within a unified technical field. The use of multiple examiners for only 3 pending office actions ensures that the prosecution of these Chemistry & Materials matters is not dependent on the discretion of a single individual.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOGUEROLA, ALEXANDER STEPHAN | 1 | 82.7% | +3.0% |
| KWAK, DEAN P | 1 | 58.7% | +37.1% |
| HERBERT, MADISON TAYLOR | 1 | 59.1% | +53.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19031280 | EVAPORATION MANAGEMENT IN DIGITAL MICROFLUIDIC DEVICES | NOGUEROLA, ALEXANDER STEPHAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18064893 | DIGITAL MICROFLUIDICS DEVICES AND METHODS OF USE THEREOF | HERBERT, MADISON TAYLOR | 26d |
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19031280 | EVAPORATION MANAGEMENT IN DIGITAL MICROFLUIDIC DEVICES | NOGUEROLA, ALEXANDER STEPHAN | — | DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18601304 | PIPETTE TIP AND MOUNTING SHAFT | KWAK, DEAN P | — | §103§112 | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18064893 | DIGITAL MICROFLUIDICS DEVICES AND METHODS OF USE THEREOF | HERBERT, MADISON TAYLOR | 1758 | §103Other | Final Rejection | 26d | Pending | Dec 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial